Anti-Candida albicanseffectiveness of citral and investigation of mode of action
- 4 October 2012
- journal article
- research article
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 50 (12) , 1536-1541
Abstract
Context: Candidiasis is a mycosis caused by Candida species, which is of clinical importance due to the increase in resistant yeasts. Candida infection has been a serious health problem due to the inappropriate use of antibiotics. Therefore, it is necessary to study molecules with an antifungal action. Citral is a monoterpene with known pharmacological properties, including antimicrobial action. Objective: The aim of this work was to determine the minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of citral and the probable mode of action. Materials and methods: The MIC of citral was determined by the broth microdilution method using Sabouraud dextrose medium. Additionally, the interference of citral in cell wall (sorbitol assay) and the binding of citral to ergosterol and cholesterol were studied, carried out by broth microdilution method. Results: The MIC and MFC of citral were 512 and 1024 µg/mL, respectively. The MIC of amphotericin B was 1 µg/mL. The mechanism of action did not involve either the cell wall or ergosterol. However, the presence of cholesterol increased the MIC of citral to 1024 µg/mL, indicating there is some interaction between citral and cholesterol. Amphotericin B was used as the positive control, and it showed a high MIC in the presence of ergosterol (32 µg/mL), while in the presence of cholesterol MIC increased to 4 µg/mL. Conclusion: Citral inhibits the growth of C. albicans. The probable mechanism of action did not involve the cell wall or ergosterol. Citral is able to interact with cholesterol. More studies are necessary to describe their effects completely.Keywords
This publication has 26 references indexed in Scilit:
- Biological properties of essential oils: an updated reviewFlavour and Fragrance Journal, 2010
- Molecular modeling of amphotericin B–ergosterol primary complex in water IIBiophysical Chemistry, 2009
- Chemical composition and antimicrobial activity of the essential oils of the Amazon Guatteriopsis speciesPhytochemistry, 2008
- In vitro activity of terpenes against Candida biofilmsInternational Journal of Antimicrobial Agents, 2008
- Biological effects of essential oils – A reviewFood and Chemical Toxicology, 2008
- Invasive fungal infections: a review of epidemiology and management optionsJournal of Medical Microbiology, 2006
- Epidemiology of Candida species infections in critically ill non-immunosuppressed patientsThe Lancet Infectious Diseases, 2003
- In vitro pharmacodynamic properties of MK-0991 determined by time-kill methodsDiagnostic Microbiology and Infectious Disease, 1999
- A Sensitive and Quick Microplate Method to Determine the Minimal Inhibitory Concentration of Plant Extracts for BacteriaPlanta Medica, 1998
- Amphotericin B toxicity and lethality: a tale of two channelsInternational Journal of Pharmaceutics, 1998